gallic acid has been researched along with Alloxan Diabetes in 40 studies
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study investigated whether gallic acid and myricetin-rich Labisia pumila extract (LP) consumption would help prevent diabetic eye disorders and some probable biochemistry involved relating to inflammation, vascular leakage, and oxidative tension." | 8.02 | Gallic acid and myricetin-rich Labisia pumila extract mitigated multiple diabetic eye disorders in rats. ( Fong, LS; Mohamed, S; Mohd Ishak, NI; Mustapha, NM; Nahar, N, 2021) |
| " officinalis fruit juice and gallic acid facilitated their glucose homeostasis; improved insulin sensitivity; reduced obesity; abridged elevated blood pressure and declined cholesterol level, and also induced adipogenesis in 3T3-L1 adipocytes." | 7.96 | Antidiabetic potential of gallic acid from Emblica officinalis: Improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signaling. ( Bakrania, AK; Patel, SS; Variya, BC, 2020) |
| "This study investigated the ameliorative effect of gallic acid (GA) on hypertriglyceridemia and fat accumulation in perirenal adipose tissues of high-fructose diet (HFD)-induced diabetic rats." | 7.88 | Gallic Acid Alleviates Hypertriglyceridemia and Fat Accumulation via Modulating Glycolysis and Lipolysis Pathways in Perirenal Adipose Tissues of Rats Fed a High-Fructose Diet. ( Chang, WC; Huang, DW; Shen, SC; Wu, JS; Yang, HJ, 2018) |
| "After induction of type 2 diabetes, diabetic rats were orally treated with 20 mg/kg body mass gallic acid and 40 mg/kg body mass p-coumaric acid for six weeks." | 5.48 | Modulation of hyperglycemia and dyslipidemia in experimental type 2 diabetes by gallic acid and p-coumaric acid: The role of adipocytokines and PPARγ. ( Abdel-Moneim, A; Ashour, MB; El-Twab, SMA; Reheim, ESA; Yousef, AI, 2018) |
| " This study investigated whether gallic acid and myricetin-rich Labisia pumila extract (LP) consumption would help prevent diabetic eye disorders and some probable biochemistry involved relating to inflammation, vascular leakage, and oxidative tension." | 4.02 | Gallic acid and myricetin-rich Labisia pumila extract mitigated multiple diabetic eye disorders in rats. ( Fong, LS; Mohamed, S; Mohd Ishak, NI; Mustapha, NM; Nahar, N, 2021) |
| " officinalis fruit juice and gallic acid facilitated their glucose homeostasis; improved insulin sensitivity; reduced obesity; abridged elevated blood pressure and declined cholesterol level, and also induced adipogenesis in 3T3-L1 adipocytes." | 3.96 | Antidiabetic potential of gallic acid from Emblica officinalis: Improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signaling. ( Bakrania, AK; Patel, SS; Variya, BC, 2020) |
| "This study investigated the ameliorative effect of gallic acid (GA) on hypertriglyceridemia and fat accumulation in perirenal adipose tissues of high-fructose diet (HFD)-induced diabetic rats." | 3.88 | Gallic Acid Alleviates Hypertriglyceridemia and Fat Accumulation via Modulating Glycolysis and Lipolysis Pathways in Perirenal Adipose Tissues of Rats Fed a High-Fructose Diet. ( Chang, WC; Huang, DW; Shen, SC; Wu, JS; Yang, HJ, 2018) |
| "Gallic acid is a type of phenolic acid that has been shown to be a potential drug candidate to treat diabetic kidney disease, an important complication of diabetes." | 1.91 | Gallic acid improves the metformin effects on diabetic kidney disease in mice. ( Hong, Y; Sun, W; Wang, J; Xu, X; Zhang, K; Zhang, L, 2023) |
| "Gallic acid is a phenolic compound with biological and pharmacological activities." | 1.62 | Hepatoprotective effect of gallic acid against type 2-induced diabetic liver injury in male rats through modulation of fetuin-A and GLP-1 with involvement of ERK1/2/NF-κB and Wnt1/β-catenin signaling pathways. ( Abd-Elmoniem, HA; Bashar, SM; Elhadidy, MG; Hamed, B; Helmy, S; Mostafa, AF, 2021) |
| " Solubility, dissolution rate, and oral bioavailability and hypoglycemic effect of the two cocrystals were evaluated." | 1.56 | The mechanism of binding with the α-glucosidase in vitro and the evaluation on hypoglycemic effect in vivo: Cocrystals involving synergism of gallic acid and conformer. ( He, B; Jia, Y; Li, M; Wang, J; Xue, N; Yang, C, 2020) |
| "and gallic acid were evaluated in experimentally induced hyperglycemic animals." | 1.51 | Wound healing activity of Terminalia bellerica Roxb. and gallic acid in experimentally induced diabetic animals. ( Gupta, A; Singh, MP; Sisodia, SS, 2019) |
| "Syringic acid (SA) is a natural phenolic compound abundantly available in edible fruits and plants." | 1.51 | Acceleration of wound healing activity with syringic acid in streptozotocin induced diabetic rats. ( Chen, J; Ma, S; Ren, J; Xu, F; Yang, M, 2019) |
| "The blood glucose of the type 1 diabetes (T1D) rats that were given intragastrically HAP-PEG-GA-INS showed an obvious downward trend." | 1.48 | Preparation and characterization of hydroxyapatite nanoparticles carrying insulin and gallic acid for insulin oral delivery. ( Ban, Q; Guan, YQ; Li, CH; Li, J; Zhang, L; Zhang, Y, 2018) |
| "Gallic acid treatment significantly lowered plasma levels of the creatinine and blood urea nitrogen and elevated the levels of the protein and albumin." | 1.48 | Gallic acid attenuates type I diabetic nephropathy in rats. ( Garud, MS; Kulkarni, YA, 2018) |
| "After induction of type 2 diabetes, diabetic rats were orally treated with 20 mg/kg body mass gallic acid and 40 mg/kg body mass p-coumaric acid for six weeks." | 1.48 | Modulation of hyperglycemia and dyslipidemia in experimental type 2 diabetes by gallic acid and p-coumaric acid: The role of adipocytokines and PPARγ. ( Abdel-Moneim, A; Ashour, MB; El-Twab, SMA; Reheim, ESA; Yousef, AI, 2018) |
| "Gallic acid treatment showed protective effects in these parameters evaluated, and also prevented a decrease in the activity of catalase and glutathione S-transferase, and vitamin C levels in the liver of diabetic rats." | 1.43 | Effects of gallic acid on delta - aminolevulinic dehydratase activity and in the biochemical, histological and oxidative stress parameters in the liver and kidney of diabetic rats. ( Baldissareli, J; Chitolina Schetinger, MR; da Costa Krewer, C; da Silva Pereira, A; de Oliveira, JS; de Oliveira, LS; Lopes, TF; Morsch, VM; Reichert, KP; Spanevello, RM; Thomé, GR, 2016) |
| " In contrast, chronic administration of GA significantly prevented cognitive deficits and biochemical alterations in the ICV-STZ rats." | 1.39 | Gallic acid prevents memory deficits and oxidative stress induced by intracerebroventricular injection of streptozotocin in rats. ( Bavarsad, K; Farbood, Y; Ghorbanzadeh, B; Mansouri, MT; Naghizadeh, B; Sarkaki, A, 2013) |
| "Hyperglycemia was induced in rats by STZ (50 mg/kg, body weight)." | 1.38 | Hypoglycaemic effect of Melothria heterophylla in streptozotocin-induced diabetic rats. ( Maity, TK; Mondal, A; Pal, D, 2012) |
| "Oral treatment with gallic acid (10 and 20mg/kg) daily for a period of 21days showed significant (P<0." | 1.37 | Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats. ( Kumar, R; Prince, PS; Punithavathi, VR; Selvakumari, J, 2011) |
| " From cumulative dose-response curves, pD2 values of various calcium antagonists for the negative inotropic activity were determined in diabetic and control hearts." | 1.28 | Effects of various calcium antagonists in isolated perfused hearts from diabetic and age-matched control rats. ( Heijnis, JB; Mathy, MJ; van Zwieten, PA, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.50) | 18.2507 |
| 2000's | 1 (2.50) | 29.6817 |
| 2010's | 29 (72.50) | 24.3611 |
| 2020's | 9 (22.50) | 2.80 |
| Authors | Studies |
|---|---|
| Nahar, N | 1 |
| Mohamed, S | 1 |
| Mustapha, NM | 1 |
| Fong, LS | 1 |
| Mohd Ishak, NI | 1 |
| Hou, Y | 1 |
| Huang, H | 1 |
| Gong, W | 1 |
| Wang, R | 1 |
| He, W | 1 |
| Wang, X | 1 |
| Hu, J | 1 |
| Mirza, AC | 1 |
| Panchal, SS | 1 |
| Allam, AA | 1 |
| Othman, SI | 1 |
| Satia, M | 1 |
| Mandhane, SN | 1 |
| Hong, Y | 1 |
| Wang, J | 2 |
| Sun, W | 1 |
| Zhang, L | 2 |
| Xu, X | 1 |
| Zhang, K | 1 |
| Singh, MP | 1 |
| Gupta, A | 1 |
| Sisodia, SS | 1 |
| Oboh, G | 1 |
| Ogunbadejo, MD | 1 |
| Ogunsuyi, OB | 1 |
| Oyeleye, SI | 1 |
| Rashedinia, M | 1 |
| Khoshnoud, MJ | 1 |
| Fahlyan, BK | 1 |
| Hashemi, SS | 1 |
| Alimohammadi, M | 1 |
| Sabahi, Z | 1 |
| Xue, N | 1 |
| He, B | 1 |
| Jia, Y | 1 |
| Yang, C | 1 |
| Li, M | 1 |
| Bashar, SM | 1 |
| Elhadidy, MG | 1 |
| Mostafa, AF | 1 |
| Hamed, B | 1 |
| Helmy, S | 1 |
| Abd-Elmoniem, HA | 1 |
| Abdel-Moneim, A | 2 |
| Yousef, AI | 2 |
| Abd El-Twab, SM | 1 |
| Abdel Reheim, ES | 1 |
| Ashour, MB | 2 |
| Ramezani-Aliakbari, F | 1 |
| Badavi, M | 1 |
| Dianat, M | 1 |
| Mard, SA | 1 |
| Ahangarpour, A | 1 |
| Taghizadeh, M | 1 |
| Rashidi, AA | 1 |
| Taherian, AA | 1 |
| Vakili, Z | 1 |
| Mehran, M | 1 |
| Zhang, Y | 1 |
| Ban, Q | 1 |
| Li, J | 1 |
| Li, CH | 1 |
| Guan, YQ | 1 |
| Garud, MS | 1 |
| Kulkarni, YA | 1 |
| Huang, DW | 1 |
| Chang, WC | 1 |
| Yang, HJ | 1 |
| Wu, JS | 1 |
| Shen, SC | 1 |
| Pereira, ADS | 1 |
| de Oliveira, LS | 2 |
| Lopes, TF | 2 |
| Baldissarelli, J | 1 |
| Palma, TV | 1 |
| Soares, MSP | 1 |
| Spohr, L | 1 |
| Morsch, VM | 2 |
| de Andrade, CM | 1 |
| Schetinger, MRC | 1 |
| Spanevello, RM | 2 |
| Pereira, MM | 1 |
| de Morais, H | 1 |
| Dos Santos Silva, E | 1 |
| Corso, CR | 1 |
| Adami, ER | 1 |
| Carlos, RM | 1 |
| Acco, A | 1 |
| Zanoveli, JM | 1 |
| El-Twab, SMA | 1 |
| Reheim, ESA | 1 |
| Variya, BC | 1 |
| Bakrania, AK | 1 |
| Patel, SS | 1 |
| Ren, J | 1 |
| Yang, M | 1 |
| Xu, F | 1 |
| Chen, J | 1 |
| Ma, S | 1 |
| Latha, RC | 2 |
| Daisy, P | 2 |
| Kade, IJ | 2 |
| Ogunbolude, Y | 1 |
| Kamdem, JP | 1 |
| Rocha, JB | 2 |
| Mansouri, MT | 1 |
| Naghizadeh, B | 1 |
| Ghorbanzadeh, B | 1 |
| Farbood, Y | 1 |
| Sarkaki, A | 1 |
| Bavarsad, K | 1 |
| Ramkumar, KM | 1 |
| Vijayakumar, RS | 1 |
| Vanitha, P | 1 |
| Suganya, N | 1 |
| Manjula, C | 1 |
| Rajaguru, P | 1 |
| Sivasubramanian, S | 1 |
| Gunasekaran, P | 1 |
| Cai, S | 1 |
| Zhong, Y | 1 |
| Li, Y | 1 |
| Huang, J | 1 |
| Zhang, J | 1 |
| Luo, G | 1 |
| Liu, Z | 1 |
| Gandhi, GR | 1 |
| Jothi, G | 1 |
| Antony, PJ | 1 |
| Balakrishna, K | 1 |
| Paulraj, MG | 1 |
| Ignacimuthu, S | 1 |
| Stalin, A | 1 |
| Al-Dhabi, NA | 1 |
| Yonguc, GN | 1 |
| Dodurga, Y | 1 |
| Adiguzel, E | 1 |
| Gundogdu, G | 1 |
| Kucukatay, V | 1 |
| Ozbal, S | 1 |
| Yilmaz, I | 1 |
| Cankurt, U | 1 |
| Yilmaz, Y | 1 |
| Akdogan, I | 1 |
| Ahad, A | 1 |
| Ahsan, H | 1 |
| Mujeeb, M | 1 |
| Siddiqui, WA | 1 |
| Ma, CT | 1 |
| Chyau, CC | 1 |
| Hsu, CC | 1 |
| Kuo, SM | 1 |
| Chuang, CW | 1 |
| Lin, HH | 1 |
| Chen, JH | 1 |
| Thomé, GR | 1 |
| Reichert, KP | 1 |
| de Oliveira, JS | 1 |
| da Silva Pereira, A | 1 |
| Baldissareli, J | 1 |
| da Costa Krewer, C | 1 |
| Chitolina Schetinger, MR | 1 |
| Loarca-Piña, G | 1 |
| Mendoza, S | 1 |
| Ramos-Gómez, M | 1 |
| Reynoso, R | 1 |
| Punithavathi, VR | 1 |
| Prince, PS | 1 |
| Kumar, R | 1 |
| Selvakumari, J | 1 |
| Deepa, B | 1 |
| Anuradha, CV | 1 |
| Patil, SB | 1 |
| Ghadyale, VA | 1 |
| Taklikar, SS | 1 |
| Kulkarni, CR | 1 |
| Arvindekar, AU | 1 |
| Naowaboot, J | 1 |
| Pannangpetch, P | 1 |
| Kukongviriyapan, V | 1 |
| Prawan, A | 1 |
| Kukongviriyapan, U | 1 |
| Itharat, A | 1 |
| Mondal, A | 1 |
| Maity, TK | 1 |
| Pal, D | 1 |
| Landrault, N | 1 |
| Poucheret, P | 1 |
| Azay, J | 1 |
| Krosniak, M | 1 |
| Gasc, F | 1 |
| Jenin, C | 1 |
| Cros, G | 1 |
| Teissedre, PL | 1 |
| Heijnis, JB | 1 |
| Mathy, MJ | 1 |
| van Zwieten, PA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Consumption of a Beverage of Chaya (Cnidoscolus Chayamansa) on Lipid Concentration, Lipid Peroxidation and Antioxidant Status of Patients With Dyslipidemia[NCT04110392] | 30 participants (Actual) | Interventional | 2019-06-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
40 other studies available for gallic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Gallic acid and myricetin-rich Labisia pumila extract mitigated multiple diabetic eye disorders in rats.
Topics: Animals; Diabetes Mellitus, Experimental; Eye Diseases; Flavonoids; Gallic Acid; Male; Plant Extract | 2021 |
Co-assembling of natural drug-food homologous molecule into composite hydrogel for accelerating diabetic wound healing.
Topics: Animals; Diabetes Mellitus, Experimental; Escherichia coli; Gallic Acid; Hydrogels; Mice; Staphyloco | 2022 |
Syringic Acid Ameliorates Cardiac, Hepatic, Renal and Neuronal Damage Induced by Chronic Hyperglycaemia in Wistar Rats: A Behavioural, Biochemical and Histological Analysis.
Topics: Adenosine Triphosphatases; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Gallic Acid; Gly | 2022 |
Gallic acid improves the metformin effects on diabetic kidney disease in mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Gallic | 2023 |
Wound healing activity of Terminalia bellerica Roxb. and gallic acid in experimentally induced diabetic animals.
Topics: Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Fruit; Gallic Acid; India; Plant E | 2019 |
Can gallic acid potentiate the antihyperglycemic effect of acarbose and metformin? Evidence from streptozotocin-induced diabetic rat model.
Topics: Acarbose; alpha-Amylases; alpha-Glucosidases; Animals; Antioxidants; Blood Glucose; Diabetes Mellitu | 2022 |
Syringic Acid: A Potential Natural Compound for the Management of Renal Oxidative Stress and Mitochondrial Biogenesis in Diabetic Rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gallic Acid; Humans; | 2021 |
The mechanism of binding with the α-glucosidase in vitro and the evaluation on hypoglycemic effect in vivo: Cocrystals involving synergism of gallic acid and conformer.
Topics: alpha-Glucosidases; Animals; Crystallization; Diabetes Mellitus, Experimental; Drug Evaluation, Prec | 2020 |
Hepatoprotective effect of gallic acid against type 2-induced diabetic liver injury in male rats through modulation of fetuin-A and GLP-1 with involvement of ERK1/2/NF-κB and Wnt1/β-catenin signaling pathways.
Topics: alpha-2-HS-Glycoprotein; Animals; beta Catenin; Diabetes Mellitus, Experimental; Diabetes Mellitus, | 2021 |
Gallic acid and p-coumaric acid attenuate type 2 diabetes-induced neurodegeneration in rats.
Topics: Animals; Antioxidants; Coumaric Acids; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; G | 2017 |
Effects of gallic acid on hemodynamic parameters and infarct size after ischemia-reperfusion in isolated rat hearts with alloxan-induced diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Gallic Acid; Hemodynamics; Male; Myocardial | 2017 |
The Protective Effect of Hydroalcoholic Extract of Rosa canina (Dog Rose) Fruit on Liver Function and Structure in Streptozotocin-Induced Diabetes in Rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Blood Glucose; Diabetes Co | 2018 |
Preparation and characterization of hydroxyapatite nanoparticles carrying insulin and gallic acid for insulin oral delivery.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Deli | 2018 |
Gallic acid attenuates type I diabetic nephropathy in rats.
Topics: Animals; Antioxidants; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Diabetes Me | 2018 |
Gallic Acid Alleviates Hypertriglyceridemia and Fat Accumulation via Modulating Glycolysis and Lipolysis Pathways in Perirenal Adipose Tissues of Rats Fed a High-Fructose Diet.
Topics: Adipose Tissue; Adiposity; Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Diet, | 2018 |
Effect of gallic acid on purinergic signaling in lymphocytes, platelets, and serum of diabetic rats.
Topics: Animals; Blood Platelets; Diabetes Mellitus, Experimental; Gallic Acid; Lymphocytes; Male; Platelet | 2018 |
The antioxidant gallic acid induces anxiolytic-, but not antidepressant-like effect, in streptozotocin-induced diabetes.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antioxidants; Anxiety; Behavior, Animal; Depres | 2018 |
Modulation of hyperglycemia and dyslipidemia in experimental type 2 diabetes by gallic acid and p-coumaric acid: The role of adipocytokines and PPARγ.
Topics: Adipokines; Animals; Coumaric Acids; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dru | 2018 |
Antidiabetic potential of gallic acid from Emblica officinalis: Improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signaling.
Topics: 3T3-L1 Cells; Adipogenesis; Animals; Diabetes Mellitus, Experimental; Fruit and Vegetable Juices; Ga | 2020 |
Acceleration of wound healing activity with syringic acid in streptozotocin induced diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Gallic Acid; Gene Expression Regulation; Insulin; Lipids; | 2019 |
Therapeutic potential of octyl gallate isolated from fruits of Terminalia bellerica in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Calcium; Cyclic AMP; Diabetes Mellitus, Experimental; Dose-Response Relation | 2013 |
Influence of gallic acid on oxidative stress-linked streptozotocin-induced pancreatic dysfunction in diabetic rats.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Gallic Acid; L-Lactate Dehydrogenase; Male; | 2014 |
Gallic acid prevents memory deficits and oxidative stress induced by intracerebroventricular injection of streptozotocin in rats.
Topics: Animals; Avoidance Learning; Diabetes Mellitus, Experimental; Gallic Acid; Injections, Intraventricu | 2013 |
Protective effect of gallic acid on alloxan-induced oxidative stress and osmotic fragility in rats.
Topics: Alloxan; Animals; Antioxidants; Biomarkers; Blood Glucose; Catalase; Cytoprotection; Diabetes Mellit | 2014 |
Blockade of the formation of insoluble ubiquitinated protein aggregates by EGCG3"Me in the alloxan-induced diabetic kidney.
Topics: Analysis of Variance; Animals; Blood Glucose; Blotting, Western; Diabetes Mellitus, Experimental; Di | 2013 |
Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Gallic Acid; Ge | 2014 |
Grape seed extract has superior beneficial effects than vitamin E on oxidative stress and apoptosis in the hippocampus of streptozotocin induced diabetic rats.
Topics: Animals; Antioxidants; Apoptosis; Blood Glucose; Body Weight; Catechin; Diabetes Mellitus, Experimen | 2015 |
Gallic acid ameliorates renal functions by inhibiting the activation of p38 MAPK in experimentally induced type 2 diabetic rats and cultured rat proximal tubular epithelial cells.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephr | 2015 |
Pepino polyphenolic extract improved oxidative, inflammatory and glycative stress in the sciatic nerves of diabetic mice.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellitus, | 2016 |
Effects of gallic acid on delta - aminolevulinic dehydratase activity and in the biochemical, histological and oxidative stress parameters in the liver and kidney of diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Catalase; Diabetes Mellitus, Experimental; Gallic Acid; Glutath | 2016 |
Antioxidant, antimutagenic, and antidiabetic activities of edible leaves from Cnidoscolus chayamansa Mc. Vaugh.
Topics: Animals; Antimutagenic Agents; Antioxidants; Catechin; Chromatography, High Pressure Liquid; Diabete | 2010 |
Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats.
Topics: Animals; Benzothiazoles; Blood Glucose; Diabetes Mellitus, Experimental; Free Radical Scavengers; Ga | 2011 |
Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Terminalia bellerica Roxb. in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Blood Proteins; C-Peptide; Cholesterol; Creatinine; Diabetes Mellitus, Exper | 2011 |
Antioxidant potential of Coriandrum sativum L. seed extract.
Topics: Animals; Antioxidants; Ascorbic Acid; Biphenyl Compounds; Blood Glucose; Coriandrum; Diabetes Mellit | 2011 |
Insulin secretagogue, alpha-glucosidase and antioxidant activity of some selected spices in streptozotocin-induced diabetic rats.
Topics: alpha-Glucosidases; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Flavonoid | 2011 |
Mulberry leaf extract stimulates glucose uptake and GLUT4 translocation in rat adipocytes.
Topics: Adipocytes; Androstadienes; Animals; Biological Transport; Cell Membrane; Diabetes Mellitus, Experim | 2012 |
Hypoglycaemic effect of Melothria heterophylla in streptozotocin-induced diabetic rats.
Topics: Animals; Cucurbitaceae; Diabetes Mellitus, Experimental; Ethnopharmacology; Gallic Acid; Hepatic Ins | 2012 |
Gallic acid modulates cerebral oxidative stress conditions and activities of enzyme-dependent signaling systems in streptozotocin-treated rats.
Topics: Acetylcholinesterase; Animals; Antioxidants; Brain; Diabetes Mellitus, Experimental; Gallic Acid; Hy | 2013 |
Effect of a polyphenols-enriched chardonnay white wine in diabetic rats.
Topics: Animals; Anthocyanins; Antioxidants; Biflavonoids; Caffeic Acids; Catechin; Chromatography, High Pre | 2003 |
Effects of various calcium antagonists in isolated perfused hearts from diabetic and age-matched control rats.
Topics: Animals; Calcium; Calcium Channel Blockers; Depression, Chemical; Diabetes Mellitus, Experimental; D | 1991 |